H. Prydz

发表

An algorithm for selection of functional siRNA sequences.

M. Amarzguioui, H. Prydz, 2004, Biochemical and biophysical research communications.

Involution of thymus and lymphoid depletion in mice expressing the hTNF transgene

H. Prydz, H. Glosli, B. Roald, 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Human TNF‐α in transgenic mice induces differential changes in redox status and glutathione‐regulating enzymes

H. Prydz, H. Glosli, K. Tronstad, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

CpG islands as gene markers in the human genome.

H. Prydz, F. Larsen, G. Gundersen, 1992, Genomics.

A tight cluster of five unrelated human genes on chromosome 16q22.1.

A. Kolstø, T. Kristensen, H. Prydz, 1993, Human molecular genetics.

PSKH1, a novel splice factor compartment-associated serine kinase.

H. Prydz, G. Brede, J. Solheim, 2002, Nucleic acids research.

The maintenance of methylation-free islands in transgenic mice.

A. Kolstø, G. Kollias, F. Grosveld, 1986, Nucleic acids research.

Down-regulated expression of PPARα target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFα

H. Prydz, H. Glosli, P. Aukrust, 2005 .

Small Maf proteins interact with the human transcription factor TCF11/Nrf1/LCR-F1.

A. Kolstø, H. Prydz, L. Luna, 1996, Nucleic acids research.

Hammerhead ribozyme design and application

H. Prydz, M. Amarzguioui, 1998, Cellular and Molecular Life Sciences CMLS.

Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes.

H. Prydz, B. Sproat, M. Grøtli, 2000, Nucleic acids research.

Sodium butyrate inhibits the expression of the human lecithin:cholesterol acyltransferase gene in HepG2 cells by a post‐transcriptional mechanism

H. Prydz, E. Gjernes, G. Skretting, 1997, FEBS Letters.

Effects of hTNFα expression in T cells on haematopoiesis in transgenic mice

G. Kollias, H. Prydz, L. Probert, 1999 .

Serum phospholipids are the main environmental determinants of activated factor VII in the most common FVII genotype. European Union Concerted Action "Clotart".

H. Prydz, G. Mariani, F. Bernardi, 1999, Haematologica.

Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma.

H. Prydz, I. Holme, I. Hjermann, 1989, Arteriosclerosis.

Association analysis of lipid levels and apolipoprotein restriction fragment length polymorphisms

O. Myklebost, B. Olaisen, H. Prydz, 1990, Human Genetics.

Regulated compartmentalization of the putative DEAD-box helicase MDDX28 within the mitochondria in COS-1 cells.

H. Prydz, O. Ottersen, R. Valgardsdottir, 2004, Experimental cell research.

Transport Signals and Transcription-dependent Nuclear Localization of the Putative DEAD-box Helicase MDDX28*

H. Prydz, R. Valgardsdottir, 2003, Journal of Biological Chemistry.

Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII.

H. Prydz, G. Mariani, F. Bernardi, 1999, Arteriosclerosis, thrombosis, and vascular biology.

STUDIES ON PROCONVERTIN (FACTOR VII). III. PREPARATION OF LIVER CELLS FOR SUSPENSION CULTURES.

H. Prydz, J. Jonsen, 1964, Scandinavian journal of clinical and laboratory investigation.

Purification of the coagulation factors VII and X from human serum. Some properties of factor VII.

H. Prydz, A. Gladhaug, Hans Prydz, 1970, Biochimica et biophysica acta.

Effects of dietary fat quantity and composition on fasting and postprandial levels of coagulation factor VII and serum choline-containing phospholipids

H. Prydz, J. I. Pedersen, M. Veierød, 2003, British Journal of Nutrition.

Molecular cloning of a putative novel human bZIP transcription factor on chromosome 17q22.

A. Kolstø, H. Prydz, C. Turc‐Carel, 1994, Genomics.

Extensive intimal apolipoprotein A1-derived amyloid deposits in a patient with an apolipoprotein A1 mutation.

M. Amarzguioui, H. Prydz, K. Sletten, 1998, Biochemical and biophysical research communications.

Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors

H. Prydz, R. Lidereau, E. Frengen, 2002, Oncogene.

Mutants of the protein serine kinase PSKH1 disassemble the Golgi apparatus.

H. Prydz, G. Brede, E. Stang, 2003, Experimental cell research.

A New Paradigm for Blood Coagulation Research

H. Prydz, 2000, Thrombosis and Haemostasis.

Coagulation Factors VIIa and Xa Induce Cell Signaling Leading to Up-regulation of the egr-1 Gene*

H. Prydz, J. Røttingen, E. Gjernes, 1999, The Journal of Biological Chemistry.

Knockdown of C‐terminal Src kinase by siRNA‐mediated RNA interference augments T cell receptor signaling in mature T cells

T. Mustelin, M. Amarzguioui, H. Prydz, 2004, European journal of immunology.

Regulation of lecithin: Cholesterol acyltransferase by TGF-β and interleukin-6

H. Prydz, E. Gjernes, G. Skretting, 1995 .

An amino acid exchange in exon I of the human lecithin: cholesterol acyltransferase (LCAT) gene is associated with fish eye disease.

H. Prydz, G. Skretting, 1992, Biochemical and biophysical research communications.

Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins

H. Prydz, P. Brandtzaeg, 1984, Nature.

NAD(P)H dehydrogenase and its role in the vitamin K (2-methyl-3-phytyl-1,4-naphthaquinone)-dependent carboxylation reaction.

H. Prydz, O. Gebhardt, R. Wallin, 1978, The Biochemical journal.

The coagulation factor VII in pregnancy

H. Prydz, K. And, 1984, British journal of haematology.

Factor VIIa Induces Tissue Factor-dependent Up-regulation of Interleukin-8 in a Human Keratinocyte Line*

H. Prydz, E. Gjernes, Xiaolin Wang, 2002, The Journal of Biological Chemistry.

Synthesis and surface availability of thromboplastin and plasminogen activator in mononuclear phagocytes

H. Prydz, 1985 .

The role of factor VII in the intrinsic pathway: a brief review.

H. Prydz, 1983, Haemostasis.

Ex vivo and In vivo Delivery of Anti-Tissue Factor Short Interfering RNA Inhibits Mouse Pulmonary Metastasis of B16 Melanoma Cells

Q. Peng, J. Nesland, M. Amarzguioui, 2006, Clinical Cancer Research.

The N-terminal activation fragment of bovine prothrombin. Immunological studies leading to a one step purification.

H. Prydz, R. Wallin, 1977, Biochimica et biophysica acta.

Purification from bovine blood of the warfarin-induced precursor of prothrombin.

H. Prydz, R. Wallin, 1975, Biochemical and biophysical research communications.

A Novel Human Chymotrypsin-like Digestive Enzyme*

H. Prydz, J. Reseland, F. Larsen, 1997, The Journal of Biological Chemistry.

Synthesis of thromboplastin (tissue factor) by endothelial cells.

H. Prydz, K. Pettersen, 1988, Haemostasis.

Overexpression of human lecithin:cholesterol acyltransferase in mice offers no protection against diet‐induced atherosclerosis Note

H. Prydz, L. Solberg, T. Hagve, 2000, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Electroimmunoassay of factor IX in hemophilia B.

H. Prydz, B. Osterud, K. Orstavik, 1975, Thrombosis research.

Some characteristics of the Coagulation Factor Xa purified from human serum.

H. Prydz, B. Osterud, T. Christensen, 1973, Biochemical Journal.

The effect of factor IX and factor X on blood platelets.

H. Prydz, B. Osterud, T. Holm, 2009, Scandinavian journal of haematology.

The genetic defect of the original Norwegian lecithin:cholesterol acyltransferase deficiency families

H. Prydz, J. Solheim, G. Skretting, 1992, FEBS letters.

Sequencing of the rat light neurofilament promoter reveals differences in methylation between expressing and non-expressing cell lines, but not tissues.

H. Prydz, M. Saarma, S. Myöhänen, 1995, Gene.

The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells

H. Prydz, M. Wiiger, 2004, Thrombosis and Haemostasis.

Homozygous Q100R mutations in the second EGF-like domain of factor VII.

H. Prydz, A. Kavlie, 1999, Blood.

The changing faces of tissue factor biology

H. Prydz, M. Wiiger, 2007, Thrombosis and Haemostasis.

The Effect of Antithrombin III on the Activity of the Coagulation Factors VII, IX and X

H. Prydz, B. Osterud, U. Abildgaard, 1976, Thrombosis and Haemostasis.

Factor VII and Tissue Thromboplastin

H. Prydz, 1969 .

The Activation of Human Factor IX

H. Prydz, K. Laake, B. Osterud, 1975, Thrombosis and Haemostasis.

STUDIES ON PROCONVERTIN (FACTOR VII).V. BIOSYNTHESIS IN SUSPENSION CULTURES OF RAT LIVER CELLS.

H. Prydz, 1964, Scandinavian journal of clinical and laboratory investigation.

Species specificity of tissue thromboplastin.

H. Prydz, H. Stormorken, T. Janson, 1984, Haemostasis.

The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.

H. Prydz, Y. Babu, S. Bantia, 2006, Thrombosis research.

A synthetic, chemically modified ribozyme eliminates amelogenin, the major translation product in developing mouse enamel in vivo.

H. Prydz, B. Sproat, P. Thrane, 1995, The EMBO journal.

The mode of action of warfarin. An intracellular precursor for factor VII in rat liver.

H. Prydz, G. Réz, 1971, Biochimica et biophysica acta.

Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor.

M. Amarzguioui, H. Prydz, E. Babaie, 2002, Nucleic acids research.

Purification of bovine prothrombin by affinity chromatography

H. Prydz, H. Prydz, R. Wallin, 1975, FEBS letters.

Studies on Tissue Thromboplastin - Its Splitting into Two Separable Parts

H. Prydz, M. Hvatum, 1969, Thrombosis and Haemostasis.

Studies on Tissue Thromboplastin - Electron Micrography

H. Prydz, T. Hovig, M. Hvatum, 1969, Thrombosis and Haemostasis.

Tolerance for mutations and chemical modifications in a siRNA.

M. Amarzguioui, H. Prydz, E. Babaie, 2003, Nucleic acids research.

Meeting Review: ESF Workshop on ‘Impact of Nucleic Acid Chemistry on Gene Function Analysis: Antisense, Aptamers, Ribozymes and RNAi’

H. Prydz, J. Engels, K. Heermeier, 2002, Comparative and functional genomics.

A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha.

Guihua Sun, M. Amarzguioui, H. Prydz, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Binding of Factor VIIa to Tissue Factor on Keratinocytes Induces Gene Expression*

H. Prydz, E. Gjernes, E. Camerer, 2000, The Journal of Biological Chemistry.

Cellular Consequences of the Initiation of Blood Coagulation

H. Prydz, J. Røttingen, E. Gjernes, 1999, Thrombosis and Haemostasis.

Rapid and simple preparation of plasmids suitable for dideoxy DNA sequencing and other purposes.

T. Kristensen, H. Prydz, F. Larsen, 1991, DNA sequence : the journal of DNA sequencing and mapping.

A methylated CpG island 3' in the apolipoprotein-E gene does not repress its transcription.

H. Prydz, F. Larsen, J. Solheim, 1993, Human molecular genetics.

Differential methylation of a CpG‐island concatemer in hemi‐ and homozygous transgenic mice

A. Kolstø, H. Prydz, Glenn Gundersen, 1991, FEBS letters.

Tissue-specific methylation of a CpG island in transgenic mice.

A. Kolstø, H. Prydz, F. Larsen, 1992, Gene.

Choice of enzymes for mapping based on CpG islands in the human genome.

H. Prydz, F. Larsen, G. Gundersen, 1992, Genetic analysis, techniques and applications.

High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1.

P. Rocca-Serra, H. Prydz, L. Taine, 2000, Genomics.

Downregulation of tissue factor by RNA interference in human melanoma LOX‐L cells reduces pulmonary metastasis in nude mice

M. Amarzguioui, H. Prydz, Mengyu Wang, 2004, International journal of cancer.

M. Amarzguioui, H. Prydz, E. Babaie, 2003, Nucleic acids research.

Optimisation d'arnsi par arni antisens

M. Amarzguioui, H. Prydz, T. Holen, 2004 .

Characterization of PSKH1, a novel human protein serine kinase with centrosomal, golgi, and nuclear localization.

H. Prydz, G. Brede, J. Solheim, 2000, Genomics.

Studies on tissue thromboplastin: I. Solubilization with sodium deoxycholate

H. Prydz, M. Hvatum, 1966 .

Constitutive and interferon-gamma-induced expression of the human proteasome subunit multicatalytic endopeptidase complex-like 1.

H. Prydz, F. Larsen, J. Solheim, 1998, Biochimica et biophysica acta.

Studies on Chick Embryo Thrombocytes

H. Stalsberg, H. Prydz, 1963, Thrombosis and Haemostasis.

Synthesis of Factor VII

H. Prydz, 1975 .

Phospholipase C‐Sensitive Factor Vii Actiy in Normal Pregnancy

H. Prydz, O. Ingebretsen, K. Dalaker, 1990 .

STUDIES ON PROCONVERTIN (FACTOR VII) II. PURIFICATION.

H. Prydz, 1964, Scandinavian journal of clinical and laboratory investigation.

Factor X

H. Prydz, A. Gladhaug, 1971, Thrombosis and Haemostasis.

STUDIES ON PROCONVERTIN (FACTOR VII). VI. THE PRODUCTION IN RABBITS OF AN ANTISERUM AGAINST FACTOR VII.

H. Prydz, 1965, Scandinavian journal of clinical and laboratory investigation.

A simple method for determination of the factor VII-phospholipid complex using Normotest.

H. Prydz, A. H. Skartlien, K. Dalaker, 1987, Thrombosis research.

STUDIES ON PROCONVERTIN (FACTOR VII). IV. THE ADSORPTION ON BARIUM SULPHATE.

H. Prydz, 1964, Scandinavian journal of clinical and laboratory investigation.

STUDIES ON PROCONVERTIN. I. GEL FILTRATION.

H. Prydz, 1963, Scandinavian journal of clinical and laboratory investigation.

A novel gene mutation in the 60s loop of human coagulation factor VII – inhibition of interdomain crosstalk

H. Prydz, M. Wiiger, H. Stormorken, 2003, Thrombosis and Haemostasis.

Characterization of a Factor VII Molecule Carrying a Mutation in the Second Epidermal Growth Factor-like Domain

H. Prydz, H. Stormorken, A. Kavlie, 1998, Thrombosis and Haemostasis.

Studies on Chick Embryo Thrombocytes

H. Stalsberg, H. Prydz, 1963, Thrombosis and Haemostasis.

Interferon Regulatory Factor 1 Mediates the Interferon-γ Induction of the Human Immunoproteasome Subunit Multicatalytic Endopeptidase Complex-like 1*

H. Prydz, G. S. Foss, 1999, The Journal of Biological Chemistry.

The presence of intact mitochondrial DNA in HeLa cell nuclei.

T. Kristensen, H. Prydz, 1986, Nucleic Acids Research.

The locus for apolipoprotein CII is closely linked to the apolipoprotein E locus on chromosome 19 in man

O. Myklebost, B. Olaisen, H. Prydz, 1984, Human Genetics.

Confirmation of the close linkage between the loci for human apolipoproteins AI and AIV by the use of a cloned cDNA probe and two restriction site polymorphisms

O. Myklebost, B. Olaisen, H. Prydz, 2004, Human Genetics.

The cell biology of triggers in coagulation.

H. Prydz, 1985, Haemostasis.

An improved method for detection of 5-methylcytosine by PCR-based genomic sequencing.

H. Prydz, H Prydz, M. Reeben, 1994, BioTechniques.

1 kb of the lactase‐phlorizin hydrolase promoter directs post‐weaning decline and small intestinal‐specific expression in transgenic mice

H. Prydz, J. Olsen, G. Hansen, 1994, FEBS letters.

The isolation and characterisation of a cDNA clone for human lecithin:cholesterol acyl transferase and its use to analyse the genes in patients with LCAT deficiency and fish eye disease.

O. Myklebost, B. Mevåg, H. Prydz, 1987, Biochemical and biophysical research communications.

Interaction of the CNC-bZIP factor TCF11/LCR-F1/Nrf1 with MafG: binding-site selection and regulation of transcription.

A. Kolstø, H. Prydz, P. Murphy, 1998, Nucleic acids research.

Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.

H. Prydz, H. Arnesen, J. I. Pedersen, 2004, Thrombosis research.

Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations.

H. Prydz, M. Pinotti, G. Mariani, 1997, Arteriosclerosis, thrombosis, and vascular biology.

No effect of an N-terminal fragment of human prothrombin on blood-platelet aggregation.

H. Prydz, T. Holm, 2009, Scandinavian journal of haematology.

Studies on the biosynthesis of factor VII (proconvertin). The mode of action of warfarin.

H. Prydz, G. Gaudernack, 1971, Biochimica et biophysica acta.

Studies on a Subcellular System for Vitamin K- Dependent Carboxylation

H. Prydz, H. Prydz, R. Wallin, 1979, Thrombosis and Haemostasis.

A Specific System for the Estimation of Prothrombin Activity

H. Prydz, A. Gladhaug, 1970, Thrombosis and Haemostasis.

Phospholipase C-sensitive factor VII complexes in dog plasma.

H. Prydz, C. Mifsud, A. Boyce, 1991, Thrombosis research.

FACTOR VII-PHOSPHOLIPID COMPLEX IN MALE SURVIVIRS OF ACUTE MYCORDIAL INFARCTION

P Smith, H. Prydz, H. Arnesen, 2009, Thrombosis and Haemostasis.

Cloning and Characterization of MDDX28, a Putative DEAD-box Helicase with Mitochondrial and Nuclear Localization*

H. Prydz, R. Valgardsdottir, G. Brede, 2001, The Journal of Biological Chemistry.

Structural organization and mapping of the human TCF11 gene.

A. Kolstø, B. Weber, K. Abel, 1995, Genomics.

No effect of factor Xa or tissue thromboplastin and factor VII on the activation of plasminogen.

H. Prydz, B. Wiman, T. Holm, 1976, Thrombosis research.

Two novel mutations in the human coagulation factor VII promoter

H. Prydz, V. Rasi, A. Kavlie, 2003, Thrombosis and Haemostasis.

The localization of a vitamin K-induced modification in an N-terminal fragment of human prothrombin.

H. Prydz, T. Skotland, B. Osterud, 1974, The Biochemical journal.

CpG islands in mammalian gene promoters are inherently resistant to de novo methylation.

A. Kolstø, H. Prydz, T. Bestor, 1992, Genetic analysis, techniques and applications.

Triggering of the extrinsic blood coagulation system

H. Prydz, 1986 .

Effect of pyridoxine on some haemostatic parameters.

H. Prydz, H. Stormorken, I. Hagen, 1983, Thrombosis research.

Inhibition of the thrombin-fibrinogen reaction by a macromolecular factor from rat liver.

H. Prydz, B. Osterud, R. Flengsrud, 1972, The Biochemical journal.

Mice transgenic for the human LCAT gene

H. Prydz, A. Mehlum, 1994, Clinical genetics.

Vitamin K--dependent clotting factors.

H. Prydz, 1977, Seminars in thrombosis and hemostasis.

No effect of ovalbumin on the thrombin/fibrinogen reaction.

H. Prydz, H. Stormorken, T. Janson, 1981, Thrombosis research.

Evaluation of the exon predictions of the GRAIL software.

H. Prydz, F. Larsen, R. Lopez, 1994, Genomics.

Modular bacterial artificial chromosome vectors for transfer of large inserts into mammalian cells.

P. D. de Jong, K. Osoegawa, H. Prydz, 2000, Genomics.

Localization of factor VII (proconvertin) in a microsomal subfraction.

H. Prydz, A. Gaarder, 1969, Biochimica et biophysica acta.

The subcellular localization of factor VII (proconvertin) in rat liver.

H. Prydz, A. Gaarder, 1967, Biochimica et biophysica acta.

Cell biology of tissue factor, the principal initiator of blood coagulation.

A. Kolstø, H. Prydz, E. Camerer, 1996, Thrombosis research.

Effects of hTNFalpha expression in T cells on haematopoiesis in transgenic mice.

G. Kollias, H. Prydz, L. Probert, 1999, European journal of haematology.

The gene cluster containing the LCAT gene is conserved between human and pig.

P. D. de Jong, H. Prydz, G. Brede, 1997, Cytogenetics and cell genetics.

Sequencing and analysis of a 35·4 kb region on the left arm of chromosome IV from Saccharomyces cerevisiae reveal 23 open reading frames

C. Sander, H. Prydz, L. Eide, 1996 .

The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells

H. Prydz, M. Wiiger, 2004 .

The nucleotide sequence of Saccharomyces cerevisiae chromosome IV.

B. Dujon, J. Ballesta, N. Biteau, 1997, Nature.

Constitutive and interferon-γ-induced expression of the human proteasome subunit multicatalytic endopeptidase complex-like 11EMBL accession number for MECL1 cDNA: Y13640.1

H. Prydz, F. Larsen, J. Solheim, 1998 .

Regulated expression of a transgene introduced on an oriP/EBNA-1 PAC shuttle vector into human cells

H. Prydz, E. Frengen, E. Gjernes, 2009, BMC biotechnology.